Skip to main content
. Author manuscript; available in PMC: 2024 Aug 2.
Published in final edited form as: Neurogastroenterol Motil. 2022 Jul 14;34(11):e14429. doi: 10.1111/nmo.14429

TABLE 3.

Primary and secondary outcome data over time

Measure Baseline (n = 27) Midtreatment (n = 21) Posttreatment (n = 20) 4-week follow-up (n = 20) Estimated changea p-valuea
IBS-SSS (1° measure) 236 (21.9) 193 (25.4) 186 (22.0) 169 (21.3) −66.5 (26.2) 0.01
Secondary IBS survey measures
 IBS-QOL 90.6 (6.3) 87.0 (6.9) 81.0 (6.5) 73.1 (5.7) −17.5 (3.6) <0.0001
 Visceral sensitivity index 42.1 (3.5) 42.4 (4.2) 36.2 (4.0) 37.3 (4.3) −4.9 (4.2) 0.25
 IBS-BRQ score 92.6 (5.6) 82.2 (5.8) 82.8 (5.6) −9.8 (5.0) 0.05
GSRS score
 Constipation 4.0 (0.22) 3.7 (0.31) 3.3 (0.26) −0.73 (0.31) 0.02
 Bloating 4.1 (0.28) 3.5 (0.29) 3.2 (0.30) −0.85 (0.33) 0.01
 Pain 3.8 (0.23) 3.3 (0.24) 3.4 (0.24) −0.44 (0.30) 0.16
 Diarrhea 2.4 (0.25) 2.2 (0.27) 1.9 (0.24) −0.51 (0.30) 0.10
 Satiety 3.9 (0.31) 3.2 (0.32) 2.9 (0.29) −1.0 (0.39) 0.01
VAS scalesb
 Abdominal discomfort 4.3 (0.46) 3.5 (0.65) 3.2 (0.56) 2.5 (0.50) −1.8 (0.63) 0.005
 Constipation 3.4 (0.52) 3.0 (0.60) 3.3 (0.66) 2.3 (0.44) −1.1 (0.59) 0.07
 Bloating 5.0 (0.46) 3.9 (0.60) 4.1 (0.61) 3.2 (0.67) −1.8 (0.60) 0.004
 Abdominal painc 1.8 (0.16) 1.5 (0.26) 1.2 (0.22) 1.5 (0.14) −0.32 (0.20) 0.12
Physical measures
 Weight, kg 66.3 (2.8) 65.9 (2.7) 65.6 (2.8) 65.7 (2.8) −0.65 (0.30) 0.03
 BMI, kg/m2 23.5 (0.72) 23.4 (0.70) 23.3 (0.71) 23.3 (0.72) −0.20 (0.11) 0.06
 Waist circumference, cm 85.4 (2.2) 82.8 (2.5) 81.9 (2.4) 79.3 (2.2) −6.2 (1.9) 0.002
 Leg strength, min 102 (17) 135 (20.1) 155 (22.5) 144 (23.9) +38.8 (18.7) 0.04
Fear of food questionnaire score 44.3 (4.1) 39.7 (4.5) 35.6 (4.3) −8.7 (3.2) 0.008
 GI fears 3.2 (0.23) 2.9 (0.27) 2.6 (0.26) −0.61 (0.24) 0.01
 Food fears 3.1 (0.24) 2.5 (0.29) 2.3 (0.32) −0.76 (0.25) 0.003
 Food avoidance 3.1 (0.27) 3.2 (0.27) 3.0 (0.30) −0.18 (0.26) 0.48
 Social impairment 1.4 (0.27) 1.1 (0.22) 0.67 (0.14) −0.72 (0.22) 0.002
 Distress/loss of pleasure 2.4 (0.34) 2.3 (0.32) 2.3 (0.32) −0.16 (0.28) 0.56
HADS score
 Anxiety score 9.7 (0.73) 9.1 (0.95) 9.1 (1.01) 8.9 (1.1) −0.79 (0.87) 0.37
 Depression score 5.4 (0.6) 5.0 (0.71) 5.0 (0.76) 4.8 (0.76) −0.59 (0.46) 0.21

Note: Pretreatment: at first Tai Chi class (Day 0); Midtreatment: 4weeks into Tai Chi program (Day 28); Posttreatment: after last Tai Chi class (Day 49); Follow-up: 4weeks after completing program (Day 77).

Abbreviations: GSRS-IBS, Gastrointestinal Symptom Rating Scale—IBS version; HADS, Hospital Anxiety and Depression Scale; IBS-SSS, IBS Symptom Severity Scale; IBS-QOL, IBS Quality of Life Scale; VAS, Visual Analog Scale.

a

Data are shown as estimated means (SE) from mixed model repeated measures analysis with unstructured covariance among the repeated measures to determine adjusted means for a measure at each study timepoint and whether there was a significant difference in measure over time from pretreatment to 4-week follow up Day 77.

b

Participants were asked to rate the severity of their constipation, bloating, or abdominal discomfort on a visual analog scale (VAS) scale from 0 to 10, 0 being no symptom and 10 being the worst severity.

c

The VAS asked participants to rate their average level of abdominal pain in the past week, 0 being the least amount of pain and 4 being the most amount of pain.